Pyxus Posts Q1 Fiscal 2027 Results, Reaffirms Full-Year Outlook

summarizeSummary

Pyxus reported Q1 fiscal 2027 sales of $437.8M and a net loss of $7.3M, while net debt fell $130.9M year-over-year to $1,108.7M. Full-year guidance was maintained.

check_boxKey Events · Earnings and Guidance · PYYX

• Q1 Results In Line

  Sales of $437.8M, a net loss of $7.3M ($0.28/share), and Adjusted EBITDA of $27.7M came in consistent with expectations and seasonal patterns.

• Balance Sheet Strengthens

  Net debt fell $130.9M year-over-year to $1,108.7M; at quarter end, no borrowings were outstanding on the $150M ABL facility.

• Full-Year Guidance Maintained

  Management reiterated fiscal 2027 guidance: net sales of $2.3B–$2.5B and Adjusted EBITDA of $210M–$240M.

• Uncommitted Inventory Rises

  Uncommitted processed tobacco inventory increased to 9.0% of total ($60.3M) from 2.4% a year ago, reflecting current supply/demand dynamics.

auto_awesomeAnalysis · PYYX · Trade & Services

First-quarter results landed broadly in line with expectations—sales slipped 14% year-over-year to $437.8 million and the company recorded a net loss of $7.3 million—but the real story lies in the balance sheet. Net debt contracted by $130.9 million from a year ago to $1,108.7 million, and the $150 million ABL facility remained completely undrawn. Against a backdrop of recent going-concern warnings and heavy leverage, this quarter demonstrates cash generation and deleveraging. Management's decision to maintain full-year guidance of $2.3–$2.5 billion in sales and $210–$240 million in Adjusted EBITDA signals confidence in the seasonal ramp. While the rise in uncommitted inventory to 9% of processed tobacco warrants attention, the liquidity and debt trends are the key positive signals here.